EPS Bio Technology smartLAB sprint nG User Manual page 80

Self-monitoring blood glucose system
Table of Contents

Advertisement

Available languages

Available languages

11. Patients undergoing oxygen therapy may have inaccurate re-
sults.
12. Altitude up to 3050 meters above sea level has no effect on
readings.
13. Test results may be false if the patient is severely dehydrated
or
severely hypertensive, in shock, or in hypoglycemic-hyperos-
molar state (with or without ketosis). Critically ill patients
should not be tested with home-use blood glucose meter.
14. Elevated cholesterol and triglyceride levels may interfere with
thewaylightisreflectedproducingerroneousmeterresults.
15. Recent studies have shown that EMI can cause electronic
medical device performance degradation and could lead to in-
appropriate therapy.
16. Lipemic samples: Cholesterol level up to 500 mg/dL (12.92
mmol/L) and triglycerides up to 3,000 mg/dL (33.6mmol/L)
do not affect the results. Grossly lipemic patient samples have
not been tested and are not recommended for testing with
smartLAB
sprint nG Blood Glucose Meter.
®
80

Advertisement

Chapters

Table of Contents
loading
Need help?

Need help?

Do you have a question about the smartLAB sprint nG and is the answer not in the manual?

Questions and answers

Table of Contents